FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.
The Howard Hughes Medical Institute abruptly ended a $60 million program to improve the retention of diverse college students
Judge Nicola Jones blasted the ‘nonsensical, ridiculous’ situation and ordered the force to hand back Melvyn Mainwaring’s phone after it was stolen by Daniel Reid
Cleveland Clinic researchers test a novel, single-dose psychedelic agent for the treatment of postpartum depression.
Italian radiologist, who says injured pet was ‘between life and death’, also operated on animal at Aosta facility
TOULOUSE, France, & BOSTON, February 06, 2025–MedTech startup REEV raises $9.2M to industrialize AI-powered robotic knee brace, transforming mobility solutions for neurological patients.
We have a general philosophy at the NFL: If a technology is not going to improve upon our current processes or make game administration faster,…
Shen et al. investigate the use of Lactobacillus plantarum, a commensal bacterial strain, as a chassis for targeting the olfactory mucosa to facilitate precise nose-to-brain delivery…
Still banned at some schools, ChatGPT gains an official role at California State University.
Endocrinological stress indicators were not associated with perceived stress, which was related to symptom severity.